WordNet

PrepTutorEJDIC

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2012/10/11 14:33:22」(JST)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 遺伝性出血性毛細血管拡張症（オースラー・ウェーバー・ランデュ症候群） hereditary hemorrhagic telangiectasia osler weber rendu syndrome
2. 肺動静脈奇形：治療 pulmonary arteriovenous malformations treatment
3. 肺動静脈奇形：診断的評価 pulmonary arteriovenous malformations diagnostic evaluation
4. 肺動静脈奇形：疫学、病因、病理、および臨床的特徴 pulmonary arteriovenous malformations epidemiology etiology pathology and clinical features
5. 脳動静脈奇形 brain arteriovenous malformations

The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?

González-Núñez M, Muñoz-Félix JM, López-Novoa JM.SourceRenal and Cardiovascular Research Unit, Department of Physiology and Pharmacology, University of Salamanca, 37007 Salamanca, Spain; Biomedical Research Institute of Salamanca (IBSAL), 37007 Salamanca, Spain; Institute Queen Sophie for Renal Research, 37007 Salamanca, Spain.
Biochimica et biophysica acta.Biochim Biophys Acta.2013 Oct;1832(10):1492-510. doi: 10.1016/j.bbadis.2013.05.016. Epub 2013 May 22.
Activin receptor-like kinase-1 or ALK-1 is a type I cell surface receptor for the transforming growth factor-β (TGF-β) family of proteins. The role of ALK-1 in endothelial cells biology and in angiogenesis has been thoroughly studied by many authors. However, it has been recently suggested a possi
PMID 23707512

Kanellopoulou T, Alexopoulou A.SourceHippokration General Hospital, Athens Medical School, Second Department of Medicine , 114, Vas. Sofia's ave, 11527 Athens , Greece.
Expert opinion on biological therapy.Expert Opin Biol Ther.2013 Sep;13(9):1315-23. doi: 10.1517/14712598.2013.813478. Epub 2013 Jul 2.
Introduction: Hereditary hemorrhagic telangiectasia (HHT) is a rare multisystem vascular disorder characterized by epistaxis, mucocutaneous telangiectases and visceral arteriovenous malformations predisposing to shunting and hemorrhage. Angiogenesis has been implicated in the pathogenesis of HHT and
PMID 23815519

A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations.

Blatt J, McLean TW, Castellino SM, Burkhart CN.SourceDivision of Pediatric Hematology Oncology, the University of North Carolina, Chapel Hill, NC, USA; Department of Pediatrics, the University of North Carolina, Chapel Hill, NC, USA. Electronic address: jblat@med.unc.edu.
Pharmacology & therapeutics.Pharmacol Ther.2013 Sep;139(3):327-33. doi: 10.1016/j.pharmthera.2013.05.001. Epub 2013 May 8.
Vascular anomalies include vascular tumors and vascular malformations. With growing pharmacologic options and parallels to cancer treatment and biology, the hematologist-oncologist has assumed a more prominent role in clinical care and research relating to these diagnoses. This also is a growing are
PMID 23665062

橋詰直樹,穴山貴嗣,久米基彦
日本呼吸器外科学会雑誌 = The journal of the Japanese Association for Chest Surgery 25(4), 406-412, 2011-05-15
症例は41歳女性．朝より呼吸困難，背部痛が出現したため近医受診．胸部造影CTにて左胸腔内出血，および左舌区末梢に径30mmの腫瘤を認めたため，肺動脈造影検査を施行したところ，A4，5を主体とするPulmonary Arteriovenous Malformation（以下PAVM）を認めた．カテーテルによる肺動脈塞栓術を試みたが，末梢の肺動脈に到達することが困難であり，時間経過とともに血胸が進行し …
NAID 10029125436